Innovation

“Early testing can avert disaster, but false positives are stressful and costly. Now there’s a solution…from a company called Cardiac Insight.”
Wall Street Journal, March 3, 2017

Read the Article
Cardea 20/20 ECG™ is the only device automated with the Refined Seattle Criteria, now evolving into the International Criteria for ECG Interpretation in Athletes.